Stage III Renal Cell Cancer AJCC v7
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB01611 | Hydroxychloroquine | 1 | Active Not Recruiting | 1 |
| DB16828 | MK-2206 | 1 | Active Not Recruiting | 1 |
| DB09035 | Nivolumab | 1 | Terminated | 1 |
| DB06176 | Romidepsin | 1 | Active Not Recruiting | 1 |
| DB00041 | Aldesleukin | 1 / 2 | Active Not Recruiting | 1 |
| DB01101 | Capecitabine | 1 / 2 | Completed | 1 |
| DB11841 | Entinostat | 1 / 2 | Active Not Recruiting | 1 |
| DB00441 | Gemcitabine | 1 / 2 | Completed | 1 |
| DB09035 | Nivolumab | 1 / 2 | Completed | 1 |
| DB15036 | Sitravatinib | 1 / 2 | Completed | 1 |
| DB00398 | Sorafenib | 1 / 2 | Completed | 1 |
| DB00112 | Bevacizumab | 2 | Completed | 1 |
| DB08875 | Cabozantinib | 2 | Active Not Recruiting | 1 |
| DB08875 | Cabozantinib | 2 | Completed | 1 |
| DB08865 | Crizotinib | 2 | Active Not Recruiting | 1 |
| DB01590 | Everolimus | 2 | Terminated | 1 |
| DB06589 | Pazopanib | 2 | Completed | 1 |
| DB12048 | Savolitinib | 2 | Active Not Recruiting | 1 |
| DB00398 | Sorafenib | 2 | Completed | 1 |
| DB01268 | Sunitinib | 2 | Active Not Recruiting | 1 |
| DB01268 | Sunitinib | 2 | Completed | 2 |
| DB12056 | Trebananib | 2 | Completed | 1 |
| DB00135 | Tyrosine | 2 | Active Not Recruiting | 1 |
| DB00112 | Bevacizumab | 3 | Terminated | 1 |
| DB01590 | Everolimus | 3 | Terminated | 1 |
| DB09035 | Nivolumab | 3 | Active Not Recruiting | 1 |
| DB00398 | Sorafenib | 3 | Completed | 1 |
| DB01268 | Sunitinib | 3 | Completed | 1 |